MILLENNIUM MANAGEMENT LLC
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 1273087
NEW YORK, NY
Position in CRNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,265,205
-$11,715,389 QoQ
Shares Held
62,368
-79.2% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Derivatives in CRNX
reported options exposure · as of Mar 31, 2024CallValue
$1,657,074
CallShares
35,400
PutValue
$1,273,232
PutShares
27,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,466,124,984 across 340 Biotechnology names. CRNX ranks #238 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in CRNX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,265,205 | 62,368 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,980,594 | 300,335 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,006,562 | 216,244 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,286,790 | 357,677 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $224,315 | 6,688 | Shares | Sole | 2025-05-15 | |
| 2024-06-30 | $1,934,211 | 43,184 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $12,405,164 | 265,011 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $1,273,232 | 27,200 | Put | Sole | 2024-05-15 | |
| 2024-03-31 | $1,657,074 | 35,400 | Call | Sole | 2024-05-15 | |
| 2023-12-31 | $1,206,162 | 33,900 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $13,293,719 | 373,629 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $889,226 | 29,900 | Put | Sole | 2023-11-14 | |
| 2023-09-30 | $8,404,494 | 282,599 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $766,354 | 42,528 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,522,600 | 94,807 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $10,531,430 | 575,488 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,319,209 | 321,752 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,499,004 | 509,330 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,183,712 | 236,160 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $936,365 | 32,959 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $254,957 | 12,112 | Shares | Sole | 2021-11-15 | |
| 2020-12-31 | $205,131 | 14,538 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $1,980,355 | 113,034 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||